Wrap Text
Successful bond placement at Hirslanden
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic”, the “Company”, or the “Group”)
4 February 2021
SUCCESSFUL BOND PLACEMENT AT HIRSLANDEN
Mediclinic International plc, the diversified international private healthcare services group,
announces that its Swiss division, Hirslanden, has successfully completed the placement of a
CHF145m fixed-rate bond at a coupon of 1.25%. The payment date is 25 February 2021 with
a five-year term. The bond will be listed on the SIX Swiss Exchange. UBS Investment Bank
and Zurcher Kantonalbank acted as joint lead managers.
Proceeds from the issue will be used to redeem the maturing CHF145m bond issued on 25
February 2015 with a coupon of 1.625%. The successful refinancing enables Hirslanden to
lower its interest expense and to extend its debt maturity profile.
About Mediclinic International plc
Mediclinic is a diversified international private healthcare services group, established in South
Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and
the UAE.
The Group’s core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the
continuum of care in such a way that the Group will be regarded as the most respected and
trusted provider of healthcare services by patients, medical practitioners, funders and
regulators of healthcare in each of its markets.
At 30 September 2020, Mediclinic comprised 76 hospitals, eight sub-acute and specialised
hospitals, 17 day case clinics and 18 outpatient clinics. Hirslanden operated 17 hospitals and
four day case clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern
Africa operations included 52 hospitals (three of which in Namibia), eight sub-acute and
specialised hospitals and 11 day case clinics (four of which operated by Intercare) across South
Africa, and more than 8 700 inpatient beds; and Mediclinic Middle East operated seven
hospitals, two day case clinics and 18 outpatient clinics with more than 900 inpatient beds in
the UAE. In addition, under management contracts, Mediclinic Middle East operates one
hospital in Abu Dhabi and will open a 200-bed hospital in the Kingdom of Saudi Arabia in mid-
2022.
The divisions' contributions to Group revenue for the financial year ended 31 March 2020 were
47% by Hirslanden, 29% by Mediclinic Southern Africa and 24% by Mediclinic Middle East.
The Company’s primary listing is on the London Stock Exchange (“LSE”) in the United
Kingdom, with secondary listings on the JSE in South Africa and the Namibian Stock Exchange
in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private
healthcare group based in the United Kingdom and listed on the LSE.
For further information, please contact:
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Ben Atwell/Ciara Martin – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Ltd)
NSX sponsor (Namibia): Simonis Storm Securities (Pty)
Date: 04-02-2021 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
